Atara Biotherapeutics, Inc. (ATRA) Total liabilities 2022–2025
Atara Biotherapeutics, Inc. (ATRA) total liabilities at each fiscal year-end, per SEC filings.
$58.7MFY2025 · since FY2022: $249.8M → $58.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $58.7M | -71.5% |
| FY2024 | $206.4M | -22.0% |
| FY2023 | $264.7M | +6.0% |
| FY2022 | $249.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice